Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NUFARM LIMITED Director's Dealing 2012

Nov 15, 2012

65453_rns_2012-11-15_75cf5df2-70a5-434f-b011-b35377245b69.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity NUFARM LIMITED ABN 37 091 323 312

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director WILLIAM BRUCE GOODFELLOW
Date of last notice 30/04/2012

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. Sulkem Company Ltd
Date of change 16/11/12
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change No. of securities held prior to change Direct:111,013 Fully Paid Ordinary SharesIndirect:Pacific Custodians Pty Ltd – 31,585 Fully PaidOrdinary SharesMA Goodfellow – 13,000 Fully Paid Ordinary Sharesand 100 NSSSt Kentigern Trust – 430,434 Fully Paid OrdinaryShares and 19,727 NSSSulkem Company Ltd – 120,744 Fully Paid OrdinarySharesAuckland Medical Research Foundation – 26,558NSSTrustees of The Goodfellow Foundation – 33,854Fully Paid Ordinary Shares and 1,338NSSWB Goodfellow and Edgar William Preston as Direct:111,013 Fully Paid Ordinary SharesIndirect:Pacific Custodians Pty Ltd – 31,585 Fully PaidOrdinary SharesMA Goodfellow – 13,000 Fully Paid Ordinary Sharesand 100 NSSSt Kentigern Trust – 430,434 Fully Paid OrdinaryShares and 19,727 NSSSulkem Company Ltd – 120,744 Fully Paid OrdinarySharesAuckland Medical Research Foundation – 26,558NSSTrustees of The Goodfellow Foundation – 33,854Fully Paid Ordinary Shares and 1,338NSSWB Goodfellow and Edgar William Preston as
Trustees of thePaid Ordinary SArchem Trading (NZ) Ltd - 531 Trust – 400,861 Fullyhares
700 NSS
Class Ordinary
Number acquire d Direct: 164 Fully Paid OrdiIndirect: (Sulkem CompaOrdinary Shares nary Sharesny Ltd) 629 Fully Paid
Number dispos ed Nil
Value/ConsiderNote: If consideration ationis non-cash, provide details and estimated valuation $5.7569
No. of securities held after change held after change Direct:111,177 Fully Paid Ordina ry Shares
Indirect:Pacific Custodians Pty Ltd – 31,585 Fully Paid
Ordinary ShareMA Goodfellow – 13,000 Fand 100 NSS sully Paid Ordinary Shares
St Kentigern Trust – 430,4Shares and 19,7Sulkem Company Ltd – 12 34 Fully Paid Ordinary27 NSS1373 Fully Paid Ordinary
SharesAuckland Medical Researc ,h Foundation – 26,558
NSSTrustees of The GoodfelloFully Paid Ordin w Foundation – 33,854ary Shares and 1,338
NSSWB Goodfellow and Edgar William Preston asTrustees of the 531 Trust – 400,861 FullyPaid Ordinary SharesArchem Trading (NZ) Ltd - 700 NSS
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Shares Issued under the Company’s Dividend Reinvestment Plan

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? No
If so, was prior written clearance provided to allow the tradeto proceed during this period?
If prior written clearance was provided, on what date was thisprovided?
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3